Effect of betahistine in treating in patients with peripheral vestibular disease

Effect of betahistine in treating in patients with peripheral vestibular disease - Use of betahistine for periperal vertigo

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032573

Enrollment

Registered

2018-06-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral vestibular disease

Interventions

Treatment of periorally administered betahistine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with eripheral vestibular disease

Exclusion criteria

Exclusion criteria: Contraindication to use betahistine

Design outcomes

Primary

Measure	Time frame
Frequency of vertigo	—

Countries

Japan

Contacts

Public ContactHideo Shojaku

University of Toyama Department of Otolaryngology

hshojaku@med.u-toyama.ac.jp0764347368

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026